January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Adial Pharmaceuticals
Adial (NASDAQ: ADIL) develops (i) medicinal therapies addiction & related disorders. Lead program in Phase 3 for alcohol use disorder in genetically identified patients (companion diagnostic).